An Ohio resolution just passed by the State’s House of Representatives, which raises the threshold for constitutional amendments from a simple majority of votes...
Whole Woman’s Health Alliance (WWHA) has filed a lawsuit against the U.S. Food and Drug Administration (FDA) requesting “declaratory and injunctive relief”...
Abortion proponents claim that if access to the abortion pill (mifepristone) is limited, women who suffer from a miscarriage or from Cushing syndrome will...
Planned Parenthood, the nation’s number one abortion corporation committing 40% of the nation’s abortions, has in recent years diversified its business by...
In August of 2022, Dr. Bhavik Kumar, the medical director of primary and trans care at Planned Parenthood Gulf Coast, told NPR...
A Georgia doctor tied to early abortion pill trials was later reprimanded by the state’s medical regulatory agency in the surgical abortion-related...
Abortion industry insiders have begun to implement a quick exit button on their websites which will redirect a potential abortion client’s browser...
The latest Planned Parenthood annual report (2021-22) has been released — and for the first time in years, the organization’s reported abortions...
GenBioPro (GBP) has filed a lawsuit before the U.S. District Court for Maryland, asking the court to preemptively block the FDA from ‘upending’...
Pro-abortion states are busy stockpiling the abortion pill mifepristone (Mifeprex), despite requirements under the U.S. Food and Drug Administration’s (FDA) REMS safety...
Abortion pill manufacturer Danco Laboratories — and multiple states that commit a large number of abortions — could be unprotected from a Washington...
With the spotlight on the abortion pill (mifepristone) as the courts wrangle over the legitimacy of the U.S. Food and Drug Administration’s...
The United States Court of Appeals for the Fifth Circuit has upheld the suspension of mail-order abortion pills and reinstated requirements that...
The abortion industry has claimed that District Court Judge Matthew J. Kacsmaryk was “biased” in rendering his decision to overturn the Food and Drug Administration’s (FDA)...